| Turchia | Austria | Spagna | |
| Terapia mirata | da $1,000 | da $12,000 | da $15,000 |
| Terapia con Lutetio-177 | da $8,800 | da $35,000 | da $12,000 |
| Terapia con Actinio-225 | da $22,955 | da $55,000 | da $45,000 |
| Oncothermia | da $450 | - | - |
Bookimed non aggiunge costi extra ai prezzi di Terapia mirata. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica per la tua Terapia mirata al tuo arrivo.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali in Terapia mirata e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di Terapia mirata.
Giorno 1: Arrivo
Giorno 2: Fase pre-operatoria
Giorno 3: Terapia mirata
Giorno 4: Fase post-operatoria
Settimana 1-2: Riabilitazione
Si prega di notare che il caso di ogni paziente è individuale e può variare.
Specializzato in terapie mirate e immunoterapia oncologica – Il Dr. Karagöz apporta oltre 20 anni di esperienza in oncologia al Centro Medico Anadolu.
La Dott.ssa Eda Tanrikulu è specializzata in oncologia medica e chemioterapia presso l'Anadolu Medical Center – classificato al 3° posto nell'esame di oncologia medica della Turchia.
Il Dott. Solak è specializzato in terapie mirate per diversi tipi di cancro, formato presso l'Istituto Oncologico dell'Università di Hacettepe e il MD Anderson Cancer Center.
Il medico è specializzato nella gestione del cancro al seno, del colon-retto e dei tumori del sistema urogenitale. Con un'ampia esperienza dal 2014 presso l'Anadolu Medical Center, il medico ha precedentemente lavorato presso il Medical Park Hospital, l'Ospedale di Educazione e Ricerca Kocaeli Derince e l'Ospedale Regionale di Educazione e Ricerca di Erzurum. Il servizio militare del medico includeva un ruolo come specialista in Oncologia Medica presso l'Accademia Medica Militare di Gülhane.<\/p>
I successi educativi includono una laurea in medicina generale presso l'Università di Istanbul e specializzazioni in medicina interna e oncologia medica. Il medico è membro dell'Associazione Medica Turca, della Società Turca di Oncologia Medica e della Società Turca di Cancro del Polmone.<\/p>
Targeted therapy is precision medicine that uses drugs to attack specific genetic mutations or proteins driving cancer growth. Unlike chemotherapy, which kills all rapidly dividing cells, this approach spares healthy tissue, reduces systemic side effects like hair loss, and requires specialized genomic testing before treatment begins.
Bookimed Expert Insight: Turkish oncology centers like Anadolu Medical Center often combine targeted therapy with immunotherapy protocols. This dual approach is facilitated by their direct collaboration with Johns Hopkins Medicine. By using genomic sequencing first, surgeons can select precise drugs like Lutetium-177, which may cost $8,800 in Turkey compared to nearly $40,000 elsewhere.
Patient Consensus: Many patients find they can continue working remotely during treatment since it avoids the severe neutropenia of chemo. Everyone emphasizes confirming that the specific mutation-targeted drug is in stock before flying to Istanbul.
Targeted therapy in Turkey primarily treats lung, breast, and colorectal cancers by identifying specific genetic mutations. Medical oncologists frequently prescribe HER2 inhibitors for breast cancer and EGFR or ALK inhibitors for non-small cell lung cancer. Specialized centers in Istanbul also prioritize melanoma, kidney, and gastrointestinal stromal tumors.
Bookimed Expert Insight: Turkish oncology centers often follow U.S. protocols due to high-level affiliations, such as Anadolu Medical Center’s partnership with Johns Hopkins Medicine. These clinics provide EGFR and ALK inhibitors at significantly lower costs than the US, where similar treatments average $40,000. Patients can save up to 93% while receiving care from professors with over 20 years of experience who have trained at global institutions like MD Anderson or Rambam.
Patient Consensus: Patients emphasize the importance of completing comprehensive NGS mutation testing before traveling. Many choose Turkey for the speed of starting targeted drug protocols once a genetic match is confirmed.
Leading Turkish oncology centers maintain elite international accreditations, ranking Turkey among the top five countries globally for facilities holding Joint Commission International (JCI) certification. These standards ensure over 1,200 quality measures are met, matching protocols used at top-tier medical institutions like the Mayo Clinic.
Bookimed Expert Insight: Anadolu Medical Center stands out because it holds both the OECI and IASIOS certificates specifically for interventional oncology. While many Turkish hospitals have JCI, finding one with these cancer-specific European credentials usually signals a more specialized multidisciplinary tumor board approach.
Patient Consensus: Patients emphasize verifying that a specific hospital's oncology department is JCI-certified on the official registry before booking. They also recommend bringing records translated into English to ensure smooth processing within these accredited systems.
Clinicians use high-throughput diagnostic tools like next-generation sequencing, liquid biopsies, and molecular profiling to personalize targeted therapy. These advanced technologies identify specific genetic mutations, such as EGFR or ALK, allowing surgeons to select medications that precisely attack cancer cells while sparing healthy tissue.
Bookimed Expert Insight: Turkish oncology centers like Anadolu Medical Center maintain a strategic partnership with Johns Hopkins Medicine. This collaboration allows patients to receive treatment based on specific U.S. clinical protocols. Our data shows that top-tier facilities combine these international standards with AI-supported 3 Tesla MRI and digital PET/CT to refine diagnostic accuracy.
Patient Consensus: Patients emphasize the importance of liquid biopsies to track how tumors evolve over time. Many recommend verifying that clinics use CAP-certified labs for genetic profiling to ensure the most accurate results for rare mutations.
Turkey offers a comprehensive spectrum of targeted therapies including monoclonal antibodies, small molecule inhibitors, and tyrosine kinase inhibitors (TKIs). Specialized oncology centers in Istanbul focus on precision medicine, utilizing genetic profiling to match patients with FDA-approved drugs for breast, lung, and colorectal cancers.
Bookimed Expert Insight: While many clinics offer targeted drugs, the highest success rates are found at centers with integrated NGS labs. Anadolu Medical Center and Memorial Sisli utilize in-house molecular testing to identify specific mutations. This eliminates the 2-week wait typical for external lab results, allowing treatment to begin faster.
Patient Consensus: Patients emphasize the importance of bringing original pathology slides from home. Having these reviewed by Turkish experts ensures the targeted drug matches the tumor’s specific genetic profile without repeating invasive biopsies.
Turkish hospitals provide comprehensive support for international patients through dedicated departments that manage logistics, translation, and medical coordination. Major facilities like Anadolu Medical Center and Memorial Health Group offer all-inclusive services covering airport transfers, local hotel bookings, and 24/7 interpreter support in over 20 languages.
Bookimed Expert Insight: Quality signals for international care are strongest at Anadolu Medical Center due to its Johns Hopkins Medicine affiliation. This partnership ensures all diagnostic and treatment protocols for targeted therapy align with U.S. standards while maintaining Turkey’s significantly lower costs.
Patient Consensus: Patients value the seamless experience provided by personal coordinators who handle everything from local SIM cards to post-treatment hotel stays. Many recommend confirming your specific coordinator's availability before arrival to ensure smooth communication during consultations.